Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Phase III Chronic Obstructive Pulmonary Disease Small Molecule Sought
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
New prescription drug which will be considered as complimentary product for our roflumilast COPD drug and can be sold to the same target group...
Contact
Participants
You
Email me a copy of this message

New prescription drug which will be considered as complimentary product for our roflumilast COPD drug and can be sold to the same target group.

Type of Business Relationship Sought

No co-funding or co-development expected from Takeda in Nordics.

FEATURED
Last Updated Jul 2014
Technology Type
Phase of Development CLINICAL TRIALS
CORPORATION